可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Fernandez PG, Snedden W , Idikio H, et al. The reversal of left ventricular hypertrophy with control of blood pressure in experimental hypertension. Scand J Lab Invest, 1984; 44: 711.
[2]张晓霞. 高血压性心肌肥厚与左室功能状态. 国外医学(生理、病理科学与临床分册) , 1987; 7 (4) : 210.
[3]Tarazi RC, Frohlich ED. Is reversal of cardiac hypertrophy a desirable goal of nti-hypertensive therapy? Circulation, 1987; 75(suppl Ⅰ) :Ⅰ-13.
[4]曲毓敏. 高血压左心室重构及对心脏功能的影响. 中国心血管杂志, 1997; 2 (3) : 175.
[5]丁小凌, 李云霞. 大鼠肾血管性高血压心肌肥厚的产生和逆转.湖南医科大学学报, 1989; 14 (3) : 209.
[6]刘正清, 陈亦刚, 李云霞, 等. 高血压左室肥厚及药物逆转时心肌形态和酶组化的变化. 湖南医科大学学报, 1992; 17 (2) : 117.
[7]Vogt M , Strauer BE. Response of hypertensive left ventricular hypertrophy and coronary microvascular disease to calcium antagonists. Am J Cardiol, 1995; 76: 24D.
[8]Oren S, Grossman E, Frohlich ED. Reduction in left ventricular mass in patients with systemic hypertension treated with enalapril, lisinoril, or fosenopril. Am J Cardiol, 1996; 77: 93.
[9]Capasso JM , Strobeck JE,Malhotra A , et al. Contractile behaviorof rat myocardium after reversal of hypertensive hypertrophy.Am J Physiol, 1982; 242: H882.
[10] Pegram BL , Frohlich ED. Cardiovascular adjustment of antiadrenergic agents. Am J Med , 1983; 75 (3A ) : 94.
[11]Drayer JI, Gardin JM ,Weber MA , et al. Cardiac muscle mass during vasodilation therapy in hypertension. Clin Pharmacol Ther, 1983; 33: 727.
[12]Pauletto P,Vescovo G, Scannapieco G, et al. Change in rat ventricular isomyosins with regression of caridiac hypertrophy. Hypertension, 1986; 8 (12) : 1143.
[13]Wicker P, Tarazi RC, Kobayashi K. Coronary blood flow during the development and regression of left ventricular hypertrophy in renovascular hypertensive rats. Am J Cardiol, 1983; 51 ( 10) :1744.